From Our Partners
Saturday, June 25, 2022
News on Pathogens and Preparedness
Global Biodefense
  • Featured
  • COVID-19
  • Funding
  • Directory
  • Jobs
  • Events
  • Subscribe
No Result
View All Result
  • Featured
  • COVID-19
  • Funding
  • Directory
  • Jobs
  • Events
  • Subscribe
No Result
View All Result
Global Biodefense
No Result
View All Result
Home Antimicrobial Resistance

Government, Pharma Leaders to Gather at Superbugs & Superdrugs

by Global Biodefense Staff
February 21, 2016
SMi Superbugs & Superdrugs 2016

A senior official from the Biomedical Advanced Research and Development Authority (BARDA) will deliver a keynote address at the 18th annual conference on Superbugs & Superdrugs taking place March 16-17, 2016 in London.

Extending portfolio partnerships to strengthen the antibiotic pipeline will be the topic of the exclusive address from Dr. Christopher Houchens, the Project Manager of BARDA’s Anti-Infective Program. Houchens will provide case studies on current partnerships and address BARDA’s efforts to combat antibiotic resistant infections. Attendees will also learn about BARDA funding opportunities and future research collaborations.

Other confirmed participants include leading executive stakeholders from pharma, government, and not-for-profit organizations. The popularity of the event highlights the imminent global threat of antimicrobial resistance and the urgency for scientists and drug developers to discover new alternatives to bacteria resistant treatments.

Prabhavathi Fernandes, Cempra Pharmaceuticals President & CEO, will explore international collaboration for successful worldwide commercialization; Line Matthiessen, Head of the European Commision’s Unit on Fighting Infectious Diseases and Advancing Public Health, will deliver the latest updates on EU’s action plan on AMR and public private partnerships; and Jean-Pierre Paccaud, Director of Business Development and Legal from Drugs for Neglected Diseases Initiative (DNDi), will delve further into global product development partnerships to foster new antibiotic treatments and discuss their responsible use.

The full agenda will feature 20 thought-provoking presentations from leading pharmaceutical organizations and industry experts; spotlight sessions on industry incentive and partnerships; progressive insight into drug discovery; best practices in antimicrobial stewardship; and topical panel debates to both new and seasoned stakeholders.

Global Biodefense is an official media partner of Superbugs & Superdrugs 2016.

From Our Partners
Tags: AntimicrobialsASPRBARDAEventsHHS

Related Posts

UK Health Security Agency Widens Monkeypox Vaccine Umbrella for Outbreak Control
Medical Countermeasures

UK Health Security Agency Widens Monkeypox Vaccine Umbrella for Outbreak Control

June 21, 2022
Biodefense Industry News
Industry News

Tonix Pharmaceuticals Opens Advanced Development Center for Vaccine Programs

June 20, 2022
Dual Use Research of Concern: NIH to Host Stakeholder Engagement Meeting on Oversight Policies
Biosecurity

Dual Use Research of Concern: NIH to Host Stakeholder Engagement Meeting on Oversight Policies

June 14, 2022
Monkeypox Cases Prompt Additional Contracts for Bavarian Nordic Vaccine
Medical Countermeasures

Monkeypox Cases Prompt Additional Contracts for Bavarian Nordic Vaccine

May 30, 2022
Load More

Latest News

Poliovirus Detected in London Sewage: Response Measures Emphasize Wastewater Surveillance and Vaccination Gaps

Poliovirus Detected in London Sewage: Response Measures Emphasize Wastewater Surveillance and Vaccination Gaps

June 22, 2022
Monkeypox Diagnostics: CDC Authorizes Five Commercial Lab Companies

Monkeypox Diagnostics: CDC Authorizes Five Commercial Lab Companies

June 22, 2022
UK Health Security Agency Widens Monkeypox Vaccine Umbrella for Outbreak Control

UK Health Security Agency Widens Monkeypox Vaccine Umbrella for Outbreak Control

June 21, 2022
Influenza Research

New Way to Identify Influenza A Virus Lights Up When Specific Virus Targets are Present

June 20, 2022

Subscribe

  • About
  • Contact
  • Privacy
  • Subscribe

© 2022 Stemar Media Group LLC

No Result
View All Result
  • Featured
  • COVID-19
  • Funding
  • Directory
  • Jobs
  • Events
  • Subscribe

© 2022 Stemar Media Group LLC